Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Gufic BioSciences Ltd (GUFICBIO) Share Price & Fundamentals

SegmentOfferingsAdvantages / MoatCustomersHigh-Margin AreasRevenue (₹ Cr.)Revenue %How We EarnPricing ModelGrowth DriversTop Brands
Pharmaceutical FormulationsWide range of lyophilized injections, generic drugs across antibiotics, antifungals, cardiac, fertility, antivirals, and consumer healthcare products.Strong manufacturing infrastructure with WHO, EU, US FDA GMP certifications and exclusive product formulations.B2B (hospitals, pharma companies) and B2C (retail consumers) targeting specialized therapy areas.Complex injectables and specialty branded products have higher margins.6544980Sales through distribution networks, hospital tie-ups, and retail channels primarily in India and exports.Direct sales with negotiated contracts, volume-based pricing, and brand-driven pricing strategies.New product launches, Indore plant ramp-up, increasing hospital penetration and export market growth.
Contract Manufacturing Organization (CMO)Contract manufacturing of pharmaceutical formulations including lyophilized injections for domestic and international clients.State-of-the-art automated plants with stringent quality controls and regulatory approvals.B2B pharmaceutical firms seeking advanced manufacturing capabilities.Specialized injectable manufacturing commands premium pricing.1000012Fee-for-service model and long-term contracts with pharma companies for production.Contractual agreements with milestone and volume-based payments.Growing demand for specialized injectable CMO services, capacity expansions, and regulatory certifications.
Active Pharmaceutical Ingredients (Bulk Drugs)Manufacture of bulk drugs focusing on anesthetics, antibiotics, antifungals, and intermediates for domestic and export markets.Specialized manufacturing expertise and growing in-house API R&D capabilities.B2B pharma companies and traders globally.Proprietary APIs and peptides development.18502Sales to pharmaceutical formulation manufacturers and export through distributors.Transactional sales with negotiated contracts and long-term supply agreements.Investment in novel chemical processes and expansion to peptides API.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions